Jacobs Levy Equity Management, Inc Heron Therapeutics, Inc. Transaction History

Jacobs Levy Equity Management, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$10.13 - $15.0 $2.99 Million - $4.43 Million	-295,276 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$13.27 - $18.48 $4.61 Million - $6.42 Million	-347,199 Reduced 54.04%	295,276 $4.58 Million
Q1 2021 May 17, 2021	BUY	$14.49 - $20.72 $8.94 Million - $12.8 Million	616,717 Added 2394.27%	642,475 $10.4 Million
Q4 2020 Feb 16, 2021	BUY	$14.61 - $22.14 $376,324 - $570,282	25,758 New	25,758 $545,000
Q2 2020 Aug 17, 2020	SELL	$10.89 - $21.47 $326,024 - $642,768	-29,938 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$10.23 - $24.56 $306,265 - $735,277	29,938 New	29,938 $351,000

180

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $127M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.